JP2005535606A5 - - Google Patents

Download PDF

Info

Publication number
JP2005535606A5
JP2005535606A5 JP2004510713A JP2004510713A JP2005535606A5 JP 2005535606 A5 JP2005535606 A5 JP 2005535606A5 JP 2004510713 A JP2004510713 A JP 2004510713A JP 2004510713 A JP2004510713 A JP 2004510713A JP 2005535606 A5 JP2005535606 A5 JP 2005535606A5
Authority
JP
Japan
Prior art keywords
iron
artemisinin
compound
protein
carrying protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004510713A
Other languages
English (en)
Japanese (ja)
Other versions
JP4440768B2 (ja
JP2005535606A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/017881 external-priority patent/WO2003103592A2/en
Publication of JP2005535606A publication Critical patent/JP2005535606A/ja
Publication of JP2005535606A5 publication Critical patent/JP2005535606A5/ja
Application granted granted Critical
Publication of JP4440768B2 publication Critical patent/JP4440768B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004510713A 2002-06-06 2003-06-06 アルテミシニン関連エンドペルオキシダーゼと鉄保有タンパク質と間の共有結合コンジュゲート、および使用方法 Expired - Fee Related JP4440768B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38692802P 2002-06-06 2002-06-06
PCT/US2003/017881 WO2003103592A2 (en) 2002-06-06 2003-06-06 Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use

Publications (3)

Publication Number Publication Date
JP2005535606A JP2005535606A (ja) 2005-11-24
JP2005535606A5 true JP2005535606A5 (enExample) 2006-06-29
JP4440768B2 JP4440768B2 (ja) 2010-03-24

Family

ID=29736235

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004510709A Pending JP2005529938A (ja) 2002-06-06 2003-06-06 癌の発症を予防または遅延するためのアルテミシニン様化合物を使用する方法
JP2004510713A Expired - Fee Related JP4440768B2 (ja) 2002-06-06 2003-06-06 アルテミシニン関連エンドペルオキシダーゼと鉄保有タンパク質と間の共有結合コンジュゲート、および使用方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2004510709A Pending JP2005529938A (ja) 2002-06-06 2003-06-06 癌の発症を予防または遅延するためのアルテミシニン様化合物を使用する方法

Country Status (11)

Country Link
US (2) US20040058981A1 (enExample)
EP (2) EP1553935A4 (enExample)
JP (2) JP2005529938A (enExample)
CN (3) CN101843904A (enExample)
AU (2) AU2003243418B2 (enExample)
BR (2) BR0312685A (enExample)
CA (2) CA2488360A1 (enExample)
NZ (2) NZ537114A (enExample)
RU (2) RU2325156C2 (enExample)
WO (1) WO2003103588A2 (enExample)
ZA (1) ZA200500023B (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE485039T1 (de) * 2003-02-12 2010-11-15 Univ Georgetown Verwendung von artemisinin zur behandlung von durch onkogene viren gebildeten tumoren und zur behandlung von viralen infektionen
US8394365B2 (en) 2003-09-17 2013-03-12 Nektar Therapeutics Multi-arm polymer prodrugs
CN1852740B (zh) * 2003-09-17 2011-05-11 耐科塔医药公司 多支链聚合物的药物前体
CN1255106C (zh) * 2003-09-26 2006-05-10 李国桥 复方青蒿素
US20050096369A1 (en) * 2003-11-04 2005-05-05 Hoang Ba X. Compositions and methods for treating cellular proliferation disorders
AU2004290983A1 (en) * 2003-11-19 2005-06-02 Vecta Ltd. Methods and compositions for the treatment of Helicobacter pylori-associated diseases using endoperoxide bridge-containing compounds
CN1311832C (zh) * 2005-01-12 2007-04-25 四川科伦药业股份有限公司 溴代二氢青蒿素的医药用途
US20060270863A1 (en) * 2005-05-27 2006-11-30 Amyris Biotechnologies Conversion of amorpha-4,11-diene to artemisinin and artemisinin precursors
NZ568049A (en) * 2005-10-20 2011-10-28 Epipharm Gmbh Treatment and prevention of benign pigmented moles (nevi) using artemisinine and the derivatives thereof
US7671067B2 (en) * 2006-02-09 2010-03-02 Enzon Pharmaceuticals, Inc. Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamtothecin
US7462627B2 (en) * 2006-02-09 2008-12-09 Enzon Pharmaceuticals, Inc. Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers
WO2007112451A2 (en) * 2006-03-28 2007-10-04 University Of Washington Covalent conjugates between endoperoxides and transferrin and lactoferrin receptor-binding agents
WO2008046109A2 (en) * 2006-10-13 2008-04-17 University Of Washington Conjugates of artemisinin-related endoperoxides and hydrazone derivatives for the treatment of cancer
KR101441709B1 (ko) 2006-11-30 2014-09-18 넥타르 테라퓨틱스 중합체 컨쥬게이트의 제조 방법
EP2109448B1 (en) * 2007-02-09 2013-09-11 Enzon Pharmaceuticals, Inc. Treatment of resistant or refractory cancers with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
CA2713557C (en) * 2008-01-30 2016-06-07 Pieris Ag Muteins of tear lipocalin having affinity to human c-met receptor tyrosine kinase and methods for obtaining the same
CN101323569B (zh) * 2008-07-24 2011-01-26 上海交通大学 倍半萜青蒿萜酯ae及其提取纯化方法
EP2331140B1 (en) * 2008-08-11 2018-07-04 Nektar Therapeutics Multi-arm polymeric alkanoate conjugates
WO2010025337A1 (en) * 2008-08-29 2010-03-04 Enzon Pharmaceuticals, Inc. Method of treating ras associated cancer
RS59607B1 (sr) 2008-09-23 2020-01-31 Nektar Therapeutics Metod metronomskog doziranja kamptotecinskih prolekova (npr. peg-irinotekan)
JP2012506380A (ja) * 2008-10-21 2012-03-15 エンゾン ファーマシューティカルズ,インコーポレーテッド 7−エチル−10−ヒドロキシカンプトテシンのマルチアーム型ポリマーコンジュゲートによる神経芽腫の治療
MX2011010961A (es) * 2009-04-23 2012-04-20 Londonpharma Ltd Formula en aspersion sublingual que comprende dihidroartemesinina.
GB2469791B (en) * 2009-04-23 2011-12-14 Londonpharma Ltd Transmucosal formulation of compounds providing dihydroartemesinin for use in the treatment of neoplastic disease
JP5624735B2 (ja) 2009-07-22 2014-11-12 国立大学法人岡山大学 フィルター
CN102399142B (zh) * 2010-09-14 2014-09-24 华北制药集团新药研究开发有限责任公司 一类倍半萜酯化合物及其制备方法和用途
US10894087B2 (en) 2010-12-22 2021-01-19 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
US20130331443A1 (en) 2010-12-22 2013-12-12 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
CN102727522B (zh) * 2011-04-08 2013-09-25 石雁羽 由溴代双氢青蒿素和Fe2+剂组成的复方双释胶囊制剂
CN103845360A (zh) * 2012-11-29 2014-06-11 昆明制药集团股份有限公司 含蒿甲醚的药物组合物、制剂及其用途
CN103405779B (zh) * 2013-07-18 2015-09-30 江苏省血吸虫病防治研究所 一种预防血吸虫感染长效青蒿琥酯药物及其制备方法
GB201800736D0 (en) 2018-01-17 2018-02-28 St Georges Hospital Medical School Combination therapy for treatment of leukemia
CN109908137B (zh) * 2019-03-11 2022-02-18 江苏省人民医院(南京医科大学第一附属医院) 青蒿素在杀伤乳腺癌干细胞的药物中的应用
CN114983999A (zh) * 2022-06-09 2022-09-02 四川大学 一种青蒿素及其衍生物的新用途、验证方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4916204A (en) * 1987-07-31 1990-04-10 Massachusetts Institute Of Technology Pure polyanhydride from dicarboxylic acid and coupling agent
FR2630329B1 (fr) * 1988-04-20 1991-07-05 Merieux Inst Conjugues macromoleculaires d'hemoglobine, leur procede de preparation et leurs applications
RU2098407C1 (ru) * 1989-09-27 1997-12-10 Рон-Пуленк Рорер С.А. Способ получения пероксиацетальлактонового соединения (варианты) и лактон
US5681811A (en) * 1993-05-10 1997-10-28 Protein Delivery, Inc. Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
US5472684A (en) * 1993-06-02 1995-12-05 Colgate Palmolive Company Oral compositions for plaque and gingivitis
US5578637A (en) * 1995-05-03 1996-11-26 University Of Washington Methods of inhibition or killing cancer cells using an endoperoxide
US5677468A (en) * 1995-06-29 1997-10-14 Hauser, Inc. Artemisinin dimer compounds having anticancer activity
US5869310A (en) * 1996-06-03 1999-02-09 Promega Corporation Isolated agarase enzyme from flavobacterium sp. strain NR19, cloned genes therefor, and expression thereof in transformed host cells
US6160004A (en) * 1997-12-30 2000-12-12 Hauser, Inc. C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumor activities
CN1084333C (zh) * 1998-06-17 2002-05-08 中国科学院上海药物研究所 新的青蒿素化合物,其制备方法以及含有它们的药物组合物
US6127405A (en) * 1998-07-10 2000-10-03 Council Of Scientific And Industrial Research Method for the use of alpha arteether as an anti-bacterial and anti-fungal agent
US6297272B1 (en) * 1999-01-12 2001-10-02 Hauser, Inc. Artemisinin analogs having antimalarial antiproliferative and antitumor activities and chemoselective methods of making the same
IN191696B (enExample) * 1999-02-12 2003-12-20 Council Scient Ind Res
GB9916012D0 (en) * 1999-07-09 1999-09-08 Ufc Limited Peroxide-based antimalarial compounds
JP2002128784A (ja) * 2000-10-25 2002-05-09 Japan Science & Technology Corp 細胞侵入型励起一重項酸素発生化合物および該化合物を含む薬剤類
JP2004530683A (ja) * 2001-05-16 2004-10-07 フォーク ファーマシューティカルス,インク. 寄生虫感染症治療のための標的への薬物送達

Similar Documents

Publication Publication Date Title
JP2005535606A5 (enExample)
Wang et al. Biomedical metal–organic framework materials: perspectives and challenges
JP2025066807A (ja) 生体直交型組成物
JP7405616B2 (ja) 生体直交型組成物
RU2004139096A (ru) Ковалентные конъюгаты между родственными артемизинину эндопероксидами и железосодержащими белками и способы применения
RU2451029C2 (ru) Производное инсулина
JP2011507933A5 (enExample)
ES2303361T3 (es) Conjugados de interferon-alfa-polimero con actividad biologica potenciada y procedimientos de preparacion de los mismos.
JP2021100937A5 (enExample)
JP2006513992A5 (enExample)
TWI315203B (en) Process for producing sterile suspensions of slightly soluble basic peptide complexes, sterile suspensions of slightly soluble basic peptide complexes, pharmaceutical formulations containing them, and the use thereof as medicaments
JPH09506087A (ja) 改良されたインターフェロン−ポリマー複合体
WO2006004959A3 (en) Pegylated interferon alpha-1b
BG108274A (bg) Конюга'и о' хидрок'иалкил'корбяла (has) и ак'ив...н ингр...ди...н'
WO2005028516A3 (en) Albumin-binding derivatives of therapeutic peptides
CN102516417A (zh) 用于传递治疗剂的以环糊精为基础的聚合物
JP2010503386A5 (enExample)
CY1113630T1 (el) Αντισωματα αντι-χεπσιδινης και χρησεις εξ αυτωn
EP2301531A3 (en) Combinations and modes of administration of therapeutic agents and combination therapy
JP2005537234A5 (enExample)
JP2016522261A5 (enExample)
JP2003113113A5 (enExample)
JP2006526590A5 (enExample)
JP2007513190A5 (enExample)
WO2003090686A3 (en) Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality